Rules-Based Medicine Introduces CardiovascularMAP™ Multiplex Biomarker Panel To Aid CVD Development

Rules-Based Medicine (RBM), a leading multiplexed biomarker testing laboratory, today announced the launch of CardiovascularMAP™, a research tool designed specifically to advance drug development aimed at the treatment of cardiovascular disease (CVD). Designed in collaboration with leading pharmaceutical and biotechnology research groups, the 50-biomarker panel combines biomarkers most commonly associated with CVD progression with additional markers to identify new patterns of disease, resulting in a potentially powerful new tool for researchers.

Source: RBM